(NASDAQ: INDV) Indivior's forecast annual revenue growth rate of 1.07% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 36.02%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 22.81%.
Indivior's revenue in 2026 is $1,181,000,000.On average, 9 Wall Street analysts forecast INDV's revenue for 2026 to be $145,829,351,696, with the lowest INDV revenue forecast at $137,713,848,391, and the highest INDV revenue forecast at $152,196,900,443. On average, 9 Wall Street analysts forecast INDV's revenue for 2027 to be $153,445,439,413, with the lowest INDV revenue forecast at $142,458,296,477, and the highest INDV revenue forecast at $166,804,806,392.
In 2028, INDV is forecast to generate $149,075,553,018 in revenue, with the lowest revenue forecast at $140,710,341,919 and the highest revenue forecast at $155,567,955,662.